WHO endorses Ebola prototype vaccine
The World Health Organisation has endorsed the final results of the clinical trial of an Ebola prototype vaccine. The global body in a statement in Geneva, Switzerland on Wednesday noted that the final trial results confirmed that the Ebola vaccine provided high protection against the disease. The vaccine called rvsv-ZEBOV, according to results published in The Lancet , was studied in a trial involving 11,841 people in Guinea in 2015. WHO’s Assistant Director-General for Health Systems and Innovation, and the study’s lead author, Dr Marie-Paule Kieny, stated that among the 5,837 people who received the vaccine, no Ebola cases were recorded 10 days or more after vaccination, while there were 23 cases about 10 days among those who did not receive the vaccine. The trial was led by WHO, together with Guinea’s Ministry of Health, Medecins sans Frontieres and the Norwegian Institute of Public Health, in collaboration with other international partners. Kieny said, “While these comp...